Skip to content

Froimson Mark

Reporting owner on Forms 3, 4 and 5, CIK 1709050.

Froimson Mark reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-17.

Issuers

IssuerRoles in the latest filingFilingsLast filed
PCRX · Pacira BioSciences, Inc.CIK 1396814director12026-11-17

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
PCRX · Pacira BioSciences, Inc.Common Stock2026-11-17U -20,136$36.56,405Form 4
PCRX · Pacira BioSciences, Inc.Common Stock2026-11-17D returned to the issuer-6,405$36.50Form 4
PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative2026-11-17D returned to the issuer-4,6930Form 4
PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative2026-11-17D returned to the issuer-8,4370Form 4
PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative2026-11-17D returned to the issuer-8,0270Form 4
PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative2026-11-17D returned to the issuer-7,6260Form 4
PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative2026-11-17D returned to the issuer-8,2250Form 4
PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative2026-11-17D returned to the issuer-12,9250Form 4
PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative2026-11-17D returned to the issuer-11,2790Form 4
PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative2026-11-17D returned to the issuer-10,8910Form 4
PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative2026-11-17D returned to the issuer-8,1440Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001628280-26-074529 Pacira BioSciences, Inc.2026-11-17